Imukin

Replacement | Medicines | 03/02/2014

The marketing authorization holder informed its supplied customers in a letter dated 31.01.2014 that a quality deviation with regard to product- and process-related impurities was found in stability tests for certain batches.

Name of the medicinal product Imukin 100 Mikrogramm/0,5 ml Injektionslösung
Marketing authorisation number(s) 1-19480
Marketing authorisation holder Boehringer Ingelheim RCV GmbH & Co KG
Batch number(s) 202794, 202794A, 204754, 204754A, 301147, 301147A, 301147B
Classification of the recall2
BASG reference number INS - 640.001 - 1002
Email

Further inquiry note